Clinical Trials · NCT03953170

Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications

WithdrawnPhase 3Teduglutide (Prohibited)
Phase
Phase 3
Recruitment status
Withdrawn
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Enrollment
0
Start date
Jun 2022
Locations
1 site, United States
Primary endpoint
Change in daily 24 hr ileostomy collection
View Teduglutide compound reference